Chair Cardiovascular Service Line
Baylor Scott & White Health
Plano, Texas, United States
Michael Mack, M.D. has practiced cardiothoracic surgery in Dallas, TX since 1982. He is board certified in Internal Medicine, General Surgery, and Thoracic Surgery and is currently the Director of the Cardiovascular Service Line for the Baylor Scott & White Health, Chair of the Baylor Scott & White Cardiovascular Governance Council and President of the Baylor Scott & White Research Institute. He has over 800 peer reviewed publications.
Dr. Mack is also the Senior Vice Chair of the Cardiothoracic Surgery Network (CTSN) of the NIH and is an Associate Editor of the Journal of American College of Cardiology ( JACC) as well as a member of the American College of Cardiology (ACC) Nominating Committee, ACC Governance Committee, ACC Innovations Work Group and is the Co-Chair of the STS/ACC National Transcatheter Valve Therapy (TVT) Registry Stakeholder Advisory Group and a member of the FDA MDEpiNet Advisory Committee. He is currently a Director of the American Board of Thoracic Surgery.
Dr. Mack was President of the Society of Thoracic Surgeons (STS) 2011 and is Past President of the Thoracic Surgery Foundation for Research and Education (TSFRE) 2009-2011, the Southern Thoracic Surgical Association (STSA) 2009 and the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2000.
He is a Master of the ACC and is an honorary member of the German Society for Thoracic and Cardiovascular Surgery and the Indian Association of Cardiovascular and Thoracic Surgery, Mexican Society of Cardiac Surgery and has received the Presidential Citation of the American College of Cardiology and the Transcatheter Cardiovascular Therapeutics (TCT) Lifetime Achievement Award.
Saturday, January 27, 2024
10:21 AM – 10:26 AM CT
The Society of Thoracic Surgeons First Annual Survey on Surgeon Compensation
Saturday, January 27, 2024
3:00 PM – 4:00 PM CT
The STS 2023 Surgeon Compensation Survey Initial Report
Saturday, January 27, 2024
3:05 PM – 3:15 PM CT
Moderated Panel Discussion and Audience Q&A: RECHARGE Trial
Sunday, January 28, 2024
7:12 AM – 8:00 AM CT
Five Year Clinical and Echocardiographic Outcomes from the PARTNER 3 Low-Risk Randomized Trial
Monday, January 29, 2024
7:15 AM – 7:25 AM CT
Panel Discussion and Audience Q&A
Monday, January 29, 2024
7:55 AM – 8:45 AM CT
The 5 Year Results of PARTNER 3 Favor More SAVR in Low-Risk Patients
Monday, January 29, 2024
9:00 AM – 9:10 AM CT